Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Phosphoramidite Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The phosphoramidite market has experienced notable expansion over recent years, with its value projected to increase from $1.07 billion in 2025 to $1.15 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This historical growth has been driven by several factors, including a rise in DNA sequencing activities, the broadening of academic research funding, a greater utilization of synthetic nucleic acids, advances in solid-phase synthesis methods, and a growing need for molecular diagnostics.
The phosphoramidite sector is projected to experience robust expansion over the coming years, with its valuation anticipated to reach $1.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.9%. This forecast period growth is driven by factors such as the proliferation of RNA-based therapeutics, advancements in gene editing techniques, heightened investment in pharmaceutical research and development, an increased need for tailor-made oligonucleotides, and the expansion of automated synthesis platforms. Among the key trends shaping the market are the growing requirement for materials used in oligonucleotide synthesis, the broadening scope of gene therapy and RNA-focused treatments, their rising utility in diagnostic and research contexts, the widespread uptake of automated solid-phase synthesis processes, and an enhanced emphasis on high-purity chemical components.
Download A Free Sample Report For Comprehensive Market Insights:
Phosphoramidite Market Development Factors: Which Trends Are Supporting Demand?
The anticipated growth of the phosphoramidite market is being driven forward by the expansion of the biopharmaceutical sector. This sector encompasses the research, development, manufacturing, and marketing of biologically based medical products, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. Its expansion is fueled by progress in biotechnology, a rising incidence of chronic diseases, and greater investments in research and development. Innovations in biotechnology—including gene editing and monoclonal antibody therapies—have led to more effective and precisely targeted treatments. As an example, in October 2025, the UK-based Office for National Statistics reported that the country’s life sciences industry in 2024 consisted of 6,170 businesses across 7,320 sites, employing 359,600 people and generating £146.9 billion ($191 billion) in turnover. The medical technology subsector was the largest in terms of both company count and workforce, accounting for 60% of all firms and 55% of total employment. Consequently, the ongoing expansion of the biopharmaceutical sector is significantly boosting the phosphoramidite market.
Phosphoramidite Market Segment Landscape: Which Areas Lead Market Development?
The phosphoramidite market covered in this report is segmented –
1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types
2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method
3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification
4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry
Subsegments:
1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites
2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites
3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites
4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites
5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites
Phosphoramidite Market Transformation Trends: Which Innovations Are Driving Change?
Leading players in the phosphoramidite market are concentrating on developing advanced DNA synthesis techniques, including convertible-preferred stock financing rounds, to boost the adoption and progress of Gibson SOLA technology for fast DNA and mRNA synthesis. Convertible-preferred stock financing is a capital-raising strategy where firms issue preferred shares that can be transformed into a set number of common shares at a later time. For example, in March 2025, Telesis Bio Inc., a biotechnology company based in the US, announced it had obtained up to $21 million in new funding to speed up the commercialization of its innovative enzymatic DNA synthesis platform, Gibson SOLA, backed by several strategic investors. This investment is intended to grow the firm’s fully enzymatic DNA synthesis technology, enhance its research, development, and manufacturing capacities, and improve access to quick, customizable long-DNA production. The company employs a proprietary enzymatic method that allows for the rapid and accurate synthesis of extended DNA sequences, tackling existing limitations linked to traditional phosphoramidite-based processes.
Phosphoramidite Market Industry Leaders And Market Competition
Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH
Access The Complete Phosphoramidite Market Report:
Phosphoramidite Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model